Los Angeles Biomedical Research Institute and Department of Medicine, Harbor-UCLA Medical Center, Torrance, California 90502, USA.
J Ren Nutr. 2010 Sep;20(5 Suppl):S29-30. doi: 10.1053/j.jrn.2010.05.008.
Obesity is a common contributing factor to the development of chronic kidney disease (CKD). Obesity participates in the genesis of CKD by predisposing to diabetic nephropathy, hypertensive nephrosclerosis, and focal and segmental glomerular sclerosis. It also predisposes to calcium oxalate and urate stones. Additionally, obesity is associated with an increased prevalence and magnitude of proteinuria and a more rapid progression to CKD. There are many mechanisms by which obesity alters renal physiology and metabolism. More effective methods for treating obesity and preventing the development and progression of obesity-associated CKD are clearly needed. Therefore, there is a greater need for a better understanding of the causes of the excessive energy intake that leads to obesity and the mechanisms responsible for the refractoriness of obese individuals to treatment.
肥胖是慢性肾脏病(CKD)发展的常见促成因素。肥胖通过易患糖尿病肾病、高血压性肾硬化和局灶节段性肾小球硬化参与 CKD 的发生。它也易患草酸钙和尿酸结石。此外,肥胖与蛋白尿的患病率和程度增加以及 CKD 进展更快相关。肥胖通过多种机制改变肾脏的生理和代谢。显然,需要更有效的方法来治疗肥胖症和预防肥胖相关 CKD 的发生和进展。因此,需要更好地了解导致肥胖的过量能量摄入的原因以及肥胖个体对治疗产生抗药性的机制。